(Q34169294)

English

Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Pat Whitworth

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Lisette Stork-Sloots

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Femke A de Snoo

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Paul Richards

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Michael Rotkis

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jennifer Beatty

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Angela Mislowsky

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

James V Pellicane

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Bichlien Nguyen

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Laura Lee

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Charles Nash

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Mark Gittleman

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Stephanie Akbari

13

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Peter D Beitsch

14

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

7 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3261-3267

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

copyright license

Creative Commons Attribution 4.0 International

7 August 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161926

5 July 2018

Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161926

5 July 2018

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161926

5 July 2018

Assignment of tumor subtype by genomic testing and pathologic-based approximations: implications on patient's management and therapy selection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161926

5 July 2018

Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161926

5 July 2018

PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161926

5 July 2018

Therapeutic implications of estrogen receptor signaling in HER2-positive breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161926

5 July 2018

Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161926

5 July 2018

A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4161926

5 July 2018

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3908-Y

21 January 2018

Identifiers

10.1245/S10434-014-3908-Y

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34169294&oldid=2196342154"